Literature DB >> 8576192

Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator.

B L Kee1, J Arias, M R Montminy.   

Abstract

The second messenger cAMP stimulates the expression of a number of target genes via the protein kinase A-mediated phosphorylation of CREB at Ser-133 (Gonzalez, G. A., and Montminy, M. R. (1989) Cell 59, 675-680). Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa CREB binding protein referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859). The mechanism by which CBP in turn mediates induction of cAMP-responsive genes is unknown but is thought to involve recruitment of basal transcription factors to the promoter. Here we demonstrate that CBP associates specifically with RNA polymerase II in HeLa nuclear extracts. This association in turn permits RNA polymerase II to be recruited to CREB in a phospho-(Ser-133)-dependent manner. As anti-CBP antiserum, which inhibits recruitment of CBP and RNA polymerase II to phospho-(Ser-133) CREB, attenuates transcriptional induction by protein kinase A in vitro, our results demonstrate that the CBP-RNA polymerase II complex is critical for expression of cAMP-responsive genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8576192     DOI: 10.1074/jbc.271.5.2373

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

Review 1.  Bromodomain motifs and "scaffolding"?

Authors:  G V Denis
Journal:  Front Biosci       Date:  2001-09-01

2.  Distinct cAMP response element-binding protein (CREB) domains stimulate different steps in a concerted mechanism of transcription activation.

Authors:  J Kim; J Lu; P G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  Functional interaction between the coactivator Drosophila CREB-binding protein and ASH1, a member of the trithorax group of chromatin modifiers.

Authors:  F Bantignies; R H Goodman; S M Smolik
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein.

Authors:  A J Shaywitz; S L Dove; J M Kornhauser; A Hochschild; M E Greenberg
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

5.  Immortalization of T lymphocytes by human T-cell leukemia virus type 1 is independent of the tax-CBP/p300 interaction.

Authors:  M D Robek; L Ratner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Mechanism by which the IFN-beta enhanceosome activates transcription.

Authors:  J Yie; K Senger; D Thanos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

7.  Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha.

Authors:  P Carrero; K Okamoto; P Coumailleau; S O'Brien; H Tanaka; L Poellinger
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

8.  CREB-Binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites.

Authors:  H L Hung; J Lau; A Y Kim; M J Weiss; G A Blobel
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

9.  Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1.

Authors:  Irene Yujnovsky; Jun Hirayama; Masao Doi; Emiliana Borrelli; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

10.  In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.

Authors:  Bryan D Griffin; Paul N Moynagh
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.